Stay updated on Linvoseltamab Window of Opportunity Trial in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Linvoseltamab Window of Opportunity Trial in Myeloma Clinical Trial page.

Latest updates to the Linvoseltamab Window of Opportunity Trial in Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedVersion 3.4.2 was added on 2026-02-06, introducing IPD Sharing, Eligibility, Outcome Measures, Arms and Interventions, Study Design, Conditions, Study Description, Study Status, and Study Identification; the prior 3.4.1 revision was deleted on 2025-12-03.SummaryDifference1.0%

- Check19 days agoChange DetectedA new Revision: v3.4.1 entry was added to the history and the previous Revision: v3.4.0 entry was removed, reflecting a routine update to the record history.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added and v3.3.3 was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry Revision: v3.3.3 is added to the record history; the HHS Vulnerability Disclosure entry and Revision: v3.3.2 are removed.SummaryDifference0.2%

- Check77 days agoChange DetectedNew history entries dated 2025-12-03 and 2025-12-02 were added to the record history, including updates to Contacts/Locations and Study Status; an entry dated 2025-10-27 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check91 days agoChange DetectedA new revision label (v3.3.2) was added and the previous revision (v3.2.0) was removed; these are administrative site version updates and do not affect study data.SummaryDifference0.1%

Stay in the know with updates to Linvoseltamab Window of Opportunity Trial in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Linvoseltamab Window of Opportunity Trial in Myeloma Clinical Trial page.